Ellsworth Advisors’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-9,451
Closed -$4.33M 186
2023
Q4
$4.33M Buy
9,451
+347
+4% +$171K 1.37% 29
2023
Q3
$4.76M Buy
9,104
+385
+4% +$181K 1.69% 11
2023
Q2
$3.9M Sell
8,719
-161
-2% -$81.1K 1.34% 33
2023
Q1
$4.31M Buy
8,880
+122
+1% +$60.3K 1.52% 20
2022
Q4
$4.25M Sell
8,758
-73
-0.8% -$38.4K 1.59% 16
2022
Q3
$4.29M Buy
8,831
+122
+1% +$59.3K 1.83% 9
2022
Q2
$4.08M Buy
8,709
+88
+1% +$39.2K 1.65% 14
2022
Q1
$4.01M Buy
8,621
+628
+8% +$263K 1.42% 28
2021
Q4
$3.71M Buy
+7,993
New +$3.54M 1.37% 28

Other funds holding HUM

Ellsworth Advisors's HUM Position: Q1 2024 in Review

Ellsworth Advisors sold out of Humana (HUM) in Q1 2024, closing a stake of 9,451 shares — an estimated $4.33M sold.

Ellsworth Advisors first reported a position in HUM in Q4 2021 and held it in 9 quarters. The position peaked at $4.76M in Q3 2023. 1,029 funds tracked by Wall St. Rank hold HUM as of Q1 2024.

  • Ellsworth Advisors reported no remaining Humana position as of Q1 2024 after selling out during the quarter.
  • Ellsworth Advisors sold 9,451 Humana shares in Q1 2024, an estimated $4.33M.
  • Ellsworth Advisors first reported a position in Humana in Q4 2021 and held it in 9 quarters.
  • Ellsworth Advisors's Humana position peaked at $4.76M in Q3 2023.
  • 1,029 funds tracked by Wall St. Rank held Humana as of Q1 2024.

Based on Ellsworth Advisors's 13F filing for Q1 2024, filed 15 Apr 2024.